πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9061016

Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoim

APREA AB Β· Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7902167

Compounds and methods for down-regulating Wrap53 protein by RNA interference

APREA AB Β· Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7759361

Azabicyclooctan-3-one derivatives and use thereof

APREA AB Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659278

Use of low molecular weight compounds for preparing a medicament useful in treating mutant

APREA AB Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7348330

1-azabicyclo [2,2,2] octan-3-one derivatives

APREA AB Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6921765

1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for tre

APREA AB Β· Granted Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired